New gene signature predicts immunotherapy success for bone marrow cancers
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical…
New study redefines high risk criteria for multiple myeloma
Researchers have found that with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should…
Combination treatment strategy uses cells’ waste removal functions to dismantle multiple myeloma
New research out of VCU Massey Comprehensive Cancer Center provides promising evidence for an innovative combination treatment strategy…
Roswell Park scientists present five key cancer studies at clinical meeting
The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society…
Small T-cell subset drives powerful multiple myeloma immunotherapy responses
Researchers from The University of Osaka find that only a small fraction of T cells may drive the…
Adult weight gain strongly linked to higher obesity-related cancer risk
New research presented at this year’s European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows…
Common cardio drugs proven safe in myeloma patients
Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact…
Statins, Diuretics, and Other Common Heart Drugs Do Not Worsen Survival in Multiple Myeloma, Scientists Report
Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials. Scientific Reports (2026). DOI:…
Longest survival in the world reported to date for multiple myeloma patients
Berenson Cancer Center published survival data analyzed by the Institute for Myeloma & Bone Cancer Research of 175…
Advances in diagnosis and management of systemic light chain amyloidosis
Systemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin…